| Chemotherapy studied in …STUDIED_INderived200 of 618show all (up to 200) |
|---|
| → studied in | NCT05981703Phase 1 · recruiting A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors · 618 trials list this drug (227 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222800Phase 3 · recruiting Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer · 618 trials list this drug (227 active) | — | — | Neoplasm by Site,Digestive System Neoplasm,Intestinal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226999Phase 2/Phase 3 · recruiting Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391774Phase 3 · recruiting Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · 618 trials list this drug (227 active) | — | — | HER2-Negative Breast Carcinoma,Estrogen Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392892Phase 2/Phase 3 · recruiting Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Gastric Neoplasm,Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476287Phase 2 · recruiting Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392429Phase 2 · active not recruiting FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia · 618 trials list this drug (227 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835893Phase 2 · recruiting Lenvatinib Plus Chemotherapy for pNET Liver Metastases · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04638751suspended ARGONAUT: Stool and Blood Sample Bank for Cancer Patients · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma,Pancreatic Carcinoma,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07044362NA · recruiting Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis · 618 trials list this drug (227 active) | — | — | Malignant Liver Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07785180recruiting A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy · 618 trials list this drug (227 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575935Phase 3 · recruiting Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial · 618 trials list this drug (227 active) | — | — | Fallopian Tube Endometrioid Tumor,Fallopian Tube Serous Neoplasm,Malignant Fallopian Tube Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05710328Phase 2 · active not recruiting Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial · 618 trials list this drug (227 active) | — | — | Invasive Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06596473Phase 1 · recruiting A Study of BG-C477 in Participants With Advanced Solid Tumors · 618 trials list this drug (227 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06724237Phase 3 · recruiting Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy · 618 trials list this drug (227 active) | — | — | Anaplastic Large Cell Lymphoma, ALK-Negative,Follicular Helper T-Cell Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04302025Phase 2 · recruiting A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC) · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111626Phase 3 · terminated Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. · 618 trials list this drug (227 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000253Phase 2 · recruiting Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma · 618 trials list this drug (227 active) | — | — | Malignant Esophageal Neoplasm,Childhood Gastric Carcinoma,Esophageal Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03177902recruiting Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327608NA · recruiting Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery · 618 trials list this drug (227 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05673148Phase 2 · recruiting Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial · 618 trials list this drug (227 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm,Oligometastatic Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06635980Phase 2 · recruiting Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer · 618 trials list this drug (227 active) | — | — | Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07293247Phase 2 · recruiting A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07613151recruiting Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study · 618 trials list this drug (227 active) | — | — | Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04570423Phase 2 · recruiting A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy · 618 trials list this drug (227 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691645Phase 2 · not yet recruiting Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07786766Phase 2 · recruiting Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma · 618 trials list this drug (227 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06385262Phase 2 · suspended TOP 2301: Neoadjuvant Chemo for NSCLC · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06803680Phase 1 · recruiting A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors · 618 trials list this drug (227 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780721Phase 2 · not yet recruiting Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06717178completed Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01180335Phase 3 · completed Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04230759Phase 2 · active not recruiting Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group · 618 trials list this drug (227 active) | — | — | Anal Carcinoma,Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07262567Phase 3 · recruiting Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07425054Phase 2 · recruiting ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer · 618 trials list this drug (227 active) | — | — | Anal Squamous Cell Carcinoma,Human Papillomavirus-Related Carcinoma,Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03943173early Phase 1 · active not recruiting Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery · 618 trials list this drug (227 active) | — | — | BRCA Hereditary Ovarian Carcinoma,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06391775Phase 1/Phase 2 · terminated Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy · 618 trials list this drug (227 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07127315NA · completed Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06501053NA · recruiting Contact Radiotherapy for Rectal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06731478Phase 3 · recruiting Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer · 618 trials list this drug (227 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07074756NA · recruiting A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial · 618 trials list this drug (227 active) | — | — | Glioblastoma,Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151940NA · recruiting PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06090864Phase 1/Phase 2 · recruiting ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells · 618 trials list this drug (227 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078604Phase 2 · recruiting A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer · 618 trials list this drug (227 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06949098Phase 2 · recruiting Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04747054Phase 3 · recruiting Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers · 618 trials list this drug (227 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06906887Phase 2 · recruiting PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07022483Phase 3 · recruiting Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer · 618 trials list this drug (227 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529809Phase 1/Phase 2 · recruiting Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer · 618 trials list this drug (227 active) | — | — | Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07168785early Phase 1 · not yet recruiting [18F]-AraG PET Imaging in LA HNSCC · 618 trials list this drug (227 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04174079NA · recruiting Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03599752Phase 2 · active not recruiting Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases · 618 trials list this drug (227 active) | — | — | Colorectal Neoplasm,Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02276443NA · active not recruiting Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm,Invasive Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997094Phase 1 · recruiting Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer · 618 trials list this drug (227 active) | — | — | Head and Neck Squamous Cell Carcinoma,Human Papillomavirus-Independent Squamous Cell Carcinoma,Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07498725Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors · 618 trials list this drug (227 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07637851Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer · 618 trials list this drug (227 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04905316Phase 2 · completed A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07572123Phase 2/Phase 3 · not yet recruiting Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma · 618 trials list this drug (227 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689539Phase 3 · not yet recruiting Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05731947Phase 1/Phase 2 · terminated Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors · 618 trials list this drug (227 active) | — | — | Solid Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06578247Phase 3 · active not recruiting Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML · 618 trials list this drug (227 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04643366Phase 2 · recruiting Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06794086Phase 3 · recruiting SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases · 618 trials list this drug (227 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896620active not recruiting Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma · 618 trials list this drug (227 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739411Phase 1 · recruiting Hyperpolarized Imaging in Diagnosing Participants With Glioma · 618 trials list this drug (227 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975516Phase 2 · terminated Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma,Oligometastatic Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339488Phase 2 · recruiting Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm,Carcinoma,Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07657130Phase 2 · recruiting Optimal Application Timing of ADC Drugs for Advanced Breast Cancer · 618 trials list this drug (227 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646080Phase 2 · not yet recruiting Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans · 618 trials list this drug (227 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03939481active not recruiting Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer · 618 trials list this drug (227 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188532NA · recruiting Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial · 618 trials list this drug (227 active) | — | — | Ewing Sarcoma,Round Cell Sarcoma with EWSR1-non-ETS Fusion | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07627620Phase 2 · not yet recruiting Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer · 618 trials list this drug (227 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620548Phase 2 · not yet recruiting Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas · 618 trials list this drug (227 active) | — | — | Glioblastoma,Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03319901Phase 1/Phase 2 · active not recruiting Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL · 618 trials list this drug (227 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07162506Phase 2 · recruiting DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI · 618 trials list this drug (227 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05145660Phase 3 · active not recruiting Optimization of Cervical Nodal CTV for Early and Medium Stage NPC · 618 trials list this drug (227 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07284394Phase 3 · not yet recruiting Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease · 618 trials list this drug (227 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602140Phase 2 · not yet recruiting TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study. · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03594630early Phase 1 · recruiting Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Rectal Neoplasm,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05255653Phase 2/Phase 3 · recruiting Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features · 618 trials list this drug (227 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03930498Phase 2 · active not recruiting Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma · 618 trials list this drug (227 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05340491Phase 3 · recruiting Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial · 618 trials list this drug (227 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05780372Phase 3 · active not recruiting Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma · 618 trials list this drug (227 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941741Phase 3 · recruiting IC Plus Low-dose Radiation Plus Cadonilimab in LANPC · 618 trials list this drug (227 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06195189Phase 1/Phase 2 · recruiting Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06431685Phase 1 · recruiting Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma,Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06800339Phase 1 · recruiting A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454720Phase 2/Phase 3 · recruiting A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561983Phase 2 · not yet recruiting Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07556848Phase 3 · not yet recruiting A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549061Phase 2 · not yet recruiting Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC · 618 trials list this drug (227 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06402708Phase 3 · recruiting Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) · 618 trials list this drug (227 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06767007Phase 2 · recruiting SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE） · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07378306Phase 2 · recruiting FMD and Neoadjuvant Chemo-immunotherapy in TNBC · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05633602Phase 3 · active not recruiting Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study · 618 trials list this drug (227 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06458244recruiting The Efficacy of Allo-HSCT in ND HR-CBF-AML · 618 trials list this drug (227 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03161522Phase 2 · recruiting Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer · 618 trials list this drug (227 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Esophageal Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288034Phase 2 · recruiting Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial · 618 trials list this drug (227 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528898Phase 2 · not yet recruiting Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183984Phase 2 · recruiting Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer · 618 trials list this drug (227 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02819752Phase 1 · terminated PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck · 618 trials list this drug (227 active) | — | — | Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122185Phase 2 · completed Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 618 trials list this drug (227 active) | — | — | Ovarian Germ Cell Tumor,Brenner Tumor,Malignant Fallopian Tube Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03785574NA · recruiting Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule · 618 trials list this drug (227 active) | — | — | Gestational Trophoblastic Tumor,Molar Pregnancy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06540066Phase 1 · terminated A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05935098Phase 1 · terminated BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors · 618 trials list this drug (227 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05763199Phase 2 · active not recruiting Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy · 618 trials list this drug (227 active) | — | — | Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07457528Phase 2 · recruiting Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC · 618 trials list this drug (227 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05378334NA · recruiting Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06408116Phase 2 · recruiting Predicting Esophageal Cancer Borders Using PET-Imaging · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07042438Phase 2 · recruiting Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells · 618 trials list this drug (227 active) | — | — | Diffuse Large B-Cell Lymphoma,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05214482Phase 1/Phase 2 · completed A Study of AK112 in Advanced Malignant Tumors · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06719700Phase 2 · recruiting Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07447570Phase 2 · recruiting Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC · 618 trials list this drug (227 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07033819Phase 2 · recruiting Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib · 618 trials list this drug (227 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437898Phase 2 · recruiting Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study · 618 trials list this drug (227 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03774732Phase 3 · active not recruiting PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013649Phase 3 · completed Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery · 618 trials list this drug (227 active) | — | — | Pancreatic Intraductal Papillary Mucinous Neoplasm,Pancreatic Adenocarcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04868877Phase 1/Phase 2 · active not recruiting Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination · 618 trials list this drug (227 active) | — | — | Malignant Gastric Neoplasm,Esophageal Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02738606Phase 2 · terminated Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery · 618 trials list this drug (227 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06353646NA · recruiting XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06610734Phase 2 · recruiting Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05488626NA · withdrawn Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07335380Phase 1 · not yet recruiting Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma · 618 trials list this drug (227 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961101Phase 1/Phase 2 · recruiting Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04334759Phase 3 · completed DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma · 618 trials list this drug (227 active) | — | — | Malignant Mesothelioma,Pleural Mesothelial Neoplasm,Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978193Phase 2 · recruiting Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma · 618 trials list this drug (227 active) | — | — | Malignant Esophageal Neoplasm,Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05909332Phase 3 · recruiting Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875781Phase 3 · recruiting Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340489Phase 2 · recruiting Serplulimab for Locally Advanced Cervical Cancer · 618 trials list this drug (227 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05826964Phase 2 · active not recruiting Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07330596Phase 2 · recruiting QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06727617Phase 2 · recruiting Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors · 618 trials list this drug (227 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717166Phase 3 · recruiting A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. · 618 trials list this drug (227 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06120374recruiting Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC · 618 trials list this drug (227 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06596018Phase 1/Phase 2 · recruiting Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy · 618 trials list this drug (227 active) | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07304388Phase 2 · completed HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC · 618 trials list this drug (227 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02806258Phase 1/Phase 2 · terminated Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102057Phase 2 · recruiting PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121505Phase 2 · recruiting Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04699539NA · completed Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07271602Phase 2 · not yet recruiting A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer. · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261592Phase 1/Phase 2 · not yet recruiting Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer · 618 trials list this drug (227 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333314Phase 2 · recruiting Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI · 618 trials list this drug (227 active) | — | — | Sarcoma,Neuroendocrine Carcinoma,Soft Tissue Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07260058Phase 1/Phase 2 · not yet recruiting Immune Cell Therapy for Advanced Solid Tumors · 618 trials list this drug (227 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Malignant Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07256002active not recruiting Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy · 618 trials list this drug (227 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05723107Phase 1 · recruiting EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01927744Phase 2 · completed Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection · 618 trials list this drug (227 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01771458Phase 2 · completed A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06228326Phase 1/Phase 2 · recruiting A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm,Adult Solid Neoplasm,Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185883Phase 1 · active not recruiting Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) · 618 trials list this drug (227 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04603586NA · completed Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187752NA · not yet recruiting Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03283384Phase 2 · active not recruiting Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. · 618 trials list this drug (227 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03721341Phase 3 · active not recruiting Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors · 618 trials list this drug (227 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07161115Phase 2 · not yet recruiting Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer · 618 trials list this drug (227 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155122Phase 2 · not yet recruiting Efficacy and Safety of Serplulimab Combined With Etoposide and Cisplatin as Neoadjuvant Therapy in Limited-Stage Small-Cell Carcinoma of the Esophageal · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03978039recruiting National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group · 618 trials list this drug (227 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070366Phase 2 · active not recruiting Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC · 618 trials list this drug (227 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06758544Phase 1/Phase 2 · recruiting A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02327078Phase 1/Phase 2 · completed A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) · 618 trials list this drug (227 active) | — | — | Lymphoma,Malignant Head and Neck Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07114666NA · not yet recruiting XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04581824Phase 2 · terminated Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06691425NA · recruiting Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma · 618 trials list this drug (227 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06896422Phase 1 · recruiting Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07108309Phase 2 · recruiting BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer · 618 trials list this drug (227 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06856187Phase 2 · recruiting Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer · 618 trials list this drug (227 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06418789Phase 2 · recruiting High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors · 618 trials list this drug (227 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101614Phase 2 · not yet recruiting A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC). · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07098949NA · not yet recruiting Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery · 618 trials list this drug (227 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691829Phase 2 · terminated Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06458257recruiting The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia · 618 trials list this drug (227 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186700Phase 2 · completed Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05755672recruiting On-treatment Biomarkers in Metastatic Colorectal Cancer for Life · 618 trials list this drug (227 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07069933Phase 2 · not yet recruiting Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options? · 618 trials list this drug (227 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07069270Phase 2 · not yet recruiting A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy · 618 trials list this drug (227 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062263Phase 3 · recruiting Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm,Biliary Tract Carcinoma,Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06370663Phase 2 · terminated First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC · 618 trials list this drug (227 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07035392Phase 2 · not yet recruiting Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC · 618 trials list this drug (227 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07035860not yet recruiting Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06728657Phase 2 · suspended Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma · 618 trials list this drug (227 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020247Phase 3 · recruiting Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study · 618 trials list this drug (227 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04952480Phase 2 · recruiting Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer · 618 trials list this drug (227 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005557Phase 3 · not yet recruiting Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer · 618 trials list this drug (227 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943820Phase 1/Phase 2 · recruiting AK129 Combination Therapy for Advanced Solid Tumors · 618 trials list this drug (227 active) | — | — | Solid Neoplasm,Head and Neck Squamous Cell Carcinoma,Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05704985Phase 1 · active not recruiting Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors · 618 trials list this drug (227 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Head and Neck Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06598527Phase 3 · recruiting Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study · 618 trials list this drug (227 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990503Phase 3 · not yet recruiting SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer · 618 trials list this drug (227 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05667948recruiting Molecular Analysis and Treatment Options of Thymic Malignancies · 618 trials list this drug (227 active) | — | — | Thymus Epithelial Neoplasm,Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117036recruiting Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III · 618 trials list this drug (227 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980792completed Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases · 618 trials list this drug (227 active) | — | — | Pancreatic Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06975917active not recruiting Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501) · 618 trials list this drug (227 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06962267Phase 2 · recruiting A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06941766Phase 1/Phase 2 · recruiting Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors · 618 trials list this drug (227 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06944587recruiting A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer · 618 trials list this drug (227 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06933394Phase 2 · recruiting Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma · 618 trials list this drug (227 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06686030Phase 2 · recruiting Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer · 618 trials list this drug (227 active) | — | — | Platinum-Sensitive Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03632135Phase 3 · completed Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma · 618 trials list this drug (227 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06196736Phase 3 · recruiting A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer · 618 trials list this drug (227 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00938145NA · active not recruiting 3 Tesla MRI in Patients With Bladder Cancer · 618 trials list this drug (227 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03353831Phase 3 · completed Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer · 618 trials list this drug (227 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |